To evaluate the role of perforin- and complement-mediated mechanisms in the tumor protection afforded by anti-Her2 vaccination, we tested the efficacy of RHuT vaccine in neuT, neuT-pfpKO, neuT-C1KO and neuT-C3KO mice. This evidence concerns the gene ERBB2 and neoplasm.